Vertex to Participate in Upcoming September Investor Conferences

Rhea-AI Summary

Vertex Pharmaceuticals (Nasdaq: VRTX) has announced its participation in two upcoming investor conferences in September 2024. Dr. Reshma Kewalramani, CEO and President, and Charles Wagner, EVP and CFO, will engage in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5 at 11:30 a.m. ET. Additionally, Susie Lisa, SVP of Investor Relations, and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Cantor Global Healthcare Conference on September 17 at 9:10 a.m. ET.

Both events will be webcast live through the Vertex website's Investors section. Replays of the conference webcasts will be archived on the company's website for future reference.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences.

• Dr. Reshma Kewalramani, Chief Executive Officer and President, and Charles Wagner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22^nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 11:30 a.m. ET.
• Susie Lisa, Senior Vice President of Investor Relations and Manisha Pai, Executive Director of Investor Relations, will participate in a fireside chat at the Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 9:10 a.m. ET.

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and Twitter/X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20240822736102/en/

Vertex Pharmaceuticals Incorporated

Investors:

InvestorInfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

When is Vertex Pharmaceuticals (VRTX) participating in the Morgan Stanley Global Healthcare Conference?

Vertex Pharmaceuticals (VRTX) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024 at 11:30 a.m. ET.

Who will represent Vertex Pharmaceuticals (VRTX) at the Cantor Global Healthcare Conference?

Susie Lisa, Senior Vice President of Investor Relations, and Manisha Pai, Executive Director of Investor Relations, will represent Vertex Pharmaceuticals (VRTX) at the Cantor Global Healthcare Conference.

Where can investors access the webcast of Vertex Pharmaceuticals' (VRTX) conference presentations?

Investors can access the live webcast of Vertex Pharmaceuticals' (VRTX) conference presentations through the company's website, www.vrtx.com, in the 'Investors' section under the 'News and Events' page.

Will replays of Vertex Pharmaceuticals' (VRTX) investor conference webcasts be available?

Yes, replays of Vertex Pharmaceuticals' (VRTX) investor conference webcasts will be archived on the company's website for future reference.